| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0605 | Amitriptyline Embonate | Inhibitor of the re-uptake of norepinephrine and serotonin, inhibiting N-methyl-D-aspartate (NMDA) receptors |
|
| DCC0606 | Amlodipine Mesylate | L-type calcium channel blocker |
|
| DCC0607 | Amoscanate | Anthelmintic agent against infections with the human hookworm |
|
| DCC0608 | Amotosalen Hydrochloride | Light-activated DNA, RNA crosslinking agent |
|
| DCC0609 | Amp-579 | Potent A1/A2A adenosine receptor agonist, protecting against myocardial infarction |
|
| DCC0610 | Ampa Stabilizer (r,r)-2a | The most potent AMPA stabilizer |
|
| DCC0611 | Amp-acrylate | Novel rapid and specific inhibitor of electrophile-sensitive DEAD-box proteins with high selectivity over the wild-type enzyme |
|
| DCC0612 | Ampk Activator C2 | Potent allosteric activator of AMPK |
|
| DCC0613 | Ampk Activator Vi | Potent allosteric activator of the AMPK |
|
| DCC0614 | ampk Agonist F17 | Novel agonist of AMPK signaling |
|
| DCC0615 | Amrc272 | Novel Metallo-β-lactamase Inhibitor |
|
| DCC0616 | Amri-59 | Novel potent inhibitor of peroxiredoxin I (PrxI), increasing cellular ROS, leading to the activation of both mitochondria- and apoptosis signal-regulated kinase-1-mediated signaling pathways |
|
| DCC0617 | Ams-glu | Novel small molecule prodrug for use with SEAKER cells, exhibiting enhanced anticancer activity |
|
| DCC0618 | Amt580-043 | Novel inhibitor of the replication of a disease-causing polyomavirus in cell culture |
|
| DCC0619 | Am-ts23 | DNA polymerase lambda and beta inhibitor |
|
| DCC0620 | An11251 | Novel Anti-Wolbachia Agent with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis |
|
| DCC0621 | An-329/10738021 | Novel Neuraminidase (NA) inhibitor |
|
| DCC0622 | An3365 | Novel potent and selective leucyl-tRNA synthetase inhibitor |
|
| DCC0623 | An3485 Hydrochloride | Inhibitor of TLR2-, TLR3-, TLR4- and TLR5-mediated TNF-α, IL-1β and IL-6 |
|
| DCC0624 | An8799 | Novel anti-filariasis agent, being effective in killing Brugia malayi, B. pahangi, and Litomosoides sigmodontis worms |
|
| DCC0625 | Anacolin | Anticholinergic agent |
|
| DCC0626 | And-302 | Novel Potent Anticonvulsant Agent with In Vitro Neuroprotection |
|
| DCC0627 | Andrographolide Analogue 3a.1 | Novel anticancer agent against metastatic Castration resistance and neuroendocrine variant prostate cancers (mCRPC/NEPC), exhibiting synergistic anticancer effect in combination with standard therapy docetaxel and cabazitaxel in mCRPC/NEPC, upregulating H |
|
| DCC0628 | Angiogenesis Agent C-30 | Novel angiogenesis agent, showing better efficacy than salidroside in enhancing the accumulation of the HIF-1α protein and stimulating the paracrine functions of skeletal muscle cells, significantly increasing the angiogenic potential of vascular endothel |
|
| DCC0629 | Angiotensin Acetate | Peptide hormone that causes vasoconstriction and an increase in blood pressure |
|
| DCC0630 | Ank-199 | Novel inducer of autophagic cell death through regulating PI3 kinase class III/beclin 1/Atg-related proteins in cisplatin-resistant CAR human oral cancer cells |
|
| DCC0631 | Ankaflavin | Novel activator of nuclear factor-erythroid-related factor 2 (Nrf-2) |
|
| DCC0632 | Annh31 | Novel potent DYRK1A Kinase Inhibitor |
|
| DCC0633 | Annh75 | Novel Potent and Selective DYRK1 Kinase Inhibitor |
|
| DCC0634 | Annonin Vi | Natural inhibitor of NADH:ubiquinone oxidoreductase |
|
